Roche Holding AG said that it is not considering another takeover bid for Illumina Inc., Roche's Chairman Franz Humer was quoted as saying. “Illumina is definitely off the table. Our counterpart wasn't ready to move from their totally unrealistic price expectation.

Roche doesn't do acquisitions that don't create value. Illumina was a "nice to have" for us, not a "must have." There are other alternatives to get access to gene-sequencing technology, that doesn't worry me," Humer said, without elaborating.